| VIATRIS INC. O.N. |
| USA |
| Gesundheit |
| US92556V1061 / A2QAME |
| VIA (Frankfurt) / VTRS (NASDAQ) |
| FRA:VIA, ETR:VIA, VIA:GR, NASDAQ:VTRS |
| S&P500 |
| https://www.viatris.com/ |
|
Viatris Inc. is a global healthcare company that delivers quality medicines and innovative solutions to improve health access worldwide. It offers a dynamic portfolio spanning generics, including commoditized, complex products and biosimilars, alongs..
>Volltext.. |
| 14942.1 Mio. EUR |
| 26231.14 Mio. EUR |
| 12195.04 Mio. EUR |
| 3361.72 Mio. EUR |
| -2998.93 Mio. EUR |
| -2.53 EUR |
| 12543.32 Mio. EUR |
| 1150.12 Mio. EUR |
| 1975.94 Mio. EUR |
| 0.21 |
| -14.16% |
| -388.5% |
| 0.41 EUR |
| 3.19% |
| 3.16% |
| 09.03.26 - 0.102972€ 24.11.25 - 0.103967994€ >weitere anzeigen... |
| - |
| VIATRIS |
| 05.05.26 |
|
||||
|